Global research on Growth Hormone Deficiency market, competition by top manufacturers, revenue, report 2017 to 2026

Growth Hormone Deficiency Market 

ReportsMonitor has added a report on Growth Hormone Deficiency Market.

This report provides a overview of the industry including definitions, classifications, applications and industry chain structure. The Growth Hormone Deficiency market market examination is provided for the Global market including development history, competitive landscape analysis, and major regions’ development status.

If you want sample of this Report -

https://www.reportsmonitor.com/request-sample/?post=277032

Summary

Growth hormone deficiency (GHD) is a rare endocrine disorder characterized by inadequate secretion of growth hormone (GH) from the anterior pituitary gland. It is a heterogeneous disorder that may present in childhood (pediatric GHD) or later in adult life (adult GHD). Reduced GH secretion predominantly results in stunted linear growth in children; therefore, the standard-of-care GH replacement therapy serves to normalize height in children. Adults with GHD generally demonstrate biochemical abnormalities, which can also be successfully treated with recombinant GH. Global Data estimates the 2016 sales for GHD at approximately $1.42 billion across the 7MM covered in this report.

Key Questions Answered

- Overall, the greatest unmet need in the GHD space is the issue with treatment adherence and compliance. There are other prominent unmet needs highlighted by the Key Opinion Leaders (KOLs). What are these? Will the pipeline drugs fulfil these unmet needs of the market?

- The 10-year forecast period will mark the launch of four pipeline long-acting GH drugs. How will the sales of the existing drugs be impacted? Which of the pipeline drugs will have the highest peak sales at the highest CAGR, and why?

Scope

- Overview of GHD, including epidemiology, etiology, pathophysiology, symptoms, diagnosis, and treatment guidelines.

- Annualized GHD therapeutics market revenue, annual cost of therapy and treatment usage pattern data from 2016 and forecast for ten years to 2026.

Reasons to buy

The report will enable you to -

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline. Additionally a list of acquisition targets included in the pipeline product company list.

If you want to check Discount on this Report -

https://www.reportsmonitor.com/check-discount/?post=277032

Table Of Contents

1 Table of Contents1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 7

2 Growth Hormone Deficiency: Executive Summary 9

2.1 GHD Market Will Exhibit Moderate Growth Between 2016 and 2026 10

2.2 Long-Acting Growth Hormones Will Fuel Market Growth and Improve the Treatment Landscape for GHD Patients 12

2.3 Payer Preferences Heavily Influence Market Shares of GH Drugs in the US 15

2.4 Disease Awareness and Stringent Regulatory and Insurance Policies Are Major Challenges in the GHD Market 16

2.5 Opportunities for New Entrants After the Launch of Long-Acting GHs Will Be Low During the Forecast Period 17

2.6 What Do Physicians Think? 17

3 Introduction 22

3.1 Catalyst 22

3.2 Related Reports 22

Continue.......

Full Report Access -

https://www.reportsmonitor.com/opportunityanalyzer-growth-hormone-deficiency-opportunity-analysis-and-forecasts-to-2026/

Reports Monitor is a platform to meet the market research and business intelligence requirements. Our aim is to change the dynamics of the Market Research industry by providing quality intelligence backed by data. Your requirement for market forecasting is fulfilled by our exclusive quantitative and analytics driven intelligence. Decision makers can now rely on our distinct data gathering methods to get factual market forecasting and detailed analysis.

Address: Office C & D - 4th Floor, Siddhi Towers, Above Rupee Bank, Kondhwa Road, Pune 411048, Maharashtra, India

This release was published on openPR.